Article(id=1292130411459666204, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292130360968630762, articleNumber=null, orderNo=null, doi=10.13699/j.cnki.1001-6821.2026.06.016, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1769702400000, receivedDateStr=2026-01-30, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1785997496713, onlineDateStr=2026-08-06, pubDate=1774627200000, pubDateStr=2026-03-28, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1785997496713, onlineIssueDateStr=2026-08-06, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1785997496713, creator=13701087609, updateTime=1785997496713, updator=13701087609, issue=Issue{id=1292130360968630762, tenantId=1146029695717560320, journalId=1246415772164075586, year='2026', volume='42', issue='6', pageStart='751', pageEnd='900', issueExtLink='null', onlineDate='null', pubDate='1774627200000', pubDateStr='2026-03-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1785997484675, creator='13701087609', updateTime=1786014452071, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1292201527440068743, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292130360968630762, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1292201527440068744, tenantId=1146029695717560320, journalId=1246415772164075586, issueId=1292130360968630762, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=856, endPage=859, ext={EN=ArticleExt(id=1292130413070278941, articleId=1292130411459666204, tenantId=1146029695717560320, journalId=1246415772164075586, language=EN, title=Sevabertinib, a novel targeted therapy for HER2-mutated advanced non-small cell lung cancer, columnId=1291339032068354347, journalTitle=Chinese Journal of Clinical Pharmacology, columnName=New Drugs Introduction, runingTitle=null, highlight=null, articleAbstract=

In May 2025, the U.S. Food and Drug Administration (FDA) accepted and granted priority review for the new drug application (NDA) for the oral human epidermal growth factor receptor 2 (HER2) inhibitor Sevabertinib (Hyrnuo, BAY 2927088), which was subsequently approved on November 19, 2025. Sevabertinib is a highly selective and reversible HER2 tyrosine kinase inhibitor indicated for adult patients with HER2-mutant advanced non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The launch of Sevabertinib provides a new oral targeted option for the adjuvant treatment of NSCLC. Clinical studies have demonstrated promising antitumor activity across different patient populations, with particularly high objective response rates (ORR) in patients without prior HER2-targeted therapy. The most common adverse events include diarrhea, hepatotoxicity, and interstitial lung disease, which are generally manageable. This review summarizes the mechanism of action, pharmacokinetics, clinical efficacy, safety profile, and drug interactions of Sevabertinib to support its rational clinical use.

, authors=Lu CAO, Wen-jing LI, authorsList=Lu CAO, Wen-jing LI, authorCompany=null, correspAuthors=Wen-jing LI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1292130413296771358, articleId=1292130411459666204, tenantId=1146029695717560320, journalId=1246415772164075586, language=CN, title=治疗HER2突变型晚期非小细胞肺癌新药Sevabertinib, columnId=1291339032219349293, journalTitle=中国临床药理学杂志, columnName=新药介绍, runingTitle=null, highlight=null, articleAbstract=

2025年5月,美国食品药品监督管理局(FDA)受理口服人表皮生长因子受体2(HER2)抑制剂Sevabertinib的新药申请(NDA)并授予优先审评资格,该药于2025年11月19日获准上市。Sevabertinib是一种高选择性、可逆的HER2酪氨酸激酶抑制剂,适用于既往接受过系统治疗的HER2激活突变晚期非小细胞肺癌(NSCLC)成人患者。Sevabertinib的上市为NSCLC的辅助治疗提供了新的口服靶向选择。临床研究显示,Sevabertinib在不同治疗人群中均表现出良好的抗肿瘤活性,尤其在未接受HER2靶向治疗患者中客观缓解率(ORR)较高。其常见不良反应包括腹泻、肝毒性及间质性肺病等,总体安全性可控。本文从作用机制、药代动力学、临床疗效、不良反应及药物相互作用等方面对Sevabertinib进行系统综述,以期为临床合理用药提供参考。

, authors=曹璐, 李文静, authorsList=曹璐, 李文静, authorCompany=null, correspAuthors=李文静, authorNote=

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

, correspAuthorsNote=
李文静,副主任药师 Tel: (025)83117533 E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=kWAi0hWaLFx6KY+3fEw5og==, magXml=7+vVNxHN6P72NoTd4hWZPQ==, pdfUrl=null, pdf=eHrUhxpL2AiLIN6+BA4yhw==, pdfFileSize=1573614, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=gXwWHYzI8ZeJCqNAS+7zbw==, mapNumber=null, fund=null)}, authors=[Author(id=1292130413598761251, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1292130413670064421, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413598761251, language=EN, stringName=Lu CAO, firstName=Lu, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292130413728784678, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413598761251, language=CN, stringName=曹璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京医科大学 附属儿童医院 药学部,江苏 南京 210008, bio={"content":"

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

"}, bioImg=null, bioContent=

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292130413523263775, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, xref=null, ext=[AuthorCompanyExt(id=1292130413531652384, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China), AuthorCompanyExt(id=1292130413540040993, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京医科大学 附属儿童医院 药学部,江苏 南京 210008)])]), Author(id=1292130413795893544, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=liwenjing_599@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1292130413888168234, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413795893544, language=EN, stringName=Wen-jing LI, firstName=Wen-jing, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292130413984637227, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413795893544, language=CN, stringName=李文静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京医科大学 附属儿童医院 药学部,江苏 南京 210008, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292130413523263775, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, xref=null, ext=[AuthorCompanyExt(id=1292130413531652384, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China), AuthorCompanyExt(id=1292130413540040993, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京医科大学 附属儿童医院 药学部,江苏 南京 210008)])])], keywords=[Keyword(id=1292130414076911916, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=EN, orderNo=1, keyword=Sevabertinib), Keyword(id=1292130414135632173, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=EN, orderNo=2, keyword=non-small cell lung cancer), Keyword(id=1292130414215323950, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=EN, orderNo=3, keyword=human epidermal growth factor receptor 2 mutation), Keyword(id=1292130414299210031, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=EN, orderNo=4, keyword=tyrosine kinase inhibitor), Keyword(id=1292130414366318896, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=EN, orderNo=5, keyword=targeted therapy), Keyword(id=1292130414450204977, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=CN, orderNo=1, keyword=Sevabertinib), Keyword(id=1292130414529896754, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=CN, orderNo=2, keyword=非小细胞肺癌), Keyword(id=1292130414601199923, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=CN, orderNo=3, keyword=人表皮生长因子受体2突变), Keyword(id=1292130414689280308, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=CN, orderNo=4, keyword=酪氨酸激酶抑制剂), Keyword(id=1292130414781554997, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, language=CN, orderNo=5, keyword=靶向治疗)], refs=null, funds=null, companyList=[AuthorCompany(id=1292130413523263775, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, xref=null, ext=[AuthorCompanyExt(id=1292130413531652384, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China), AuthorCompanyExt(id=1292130413540040993, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京医科大学 附属儿童医院 药学部,江苏 南京 210008)])], figs=null, attaches=null, journal=Journal(id=1246415058658443328, delFlag=0, nameCn=中国临床药理学杂志, nameEn=Chinese Journal of Clinical Pharmacology, nameHistory1=null, nameHistory2=null, issn=1001-6821, eissn=null, cn=11-2220/R, coden=null, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=8cEfS7jvj/ukyhKVOMJePA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Clinical Pharmacology, journalRemark=null, publicationField=null, createdTime=1775098107259, updatedTime=1788948995538, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=8cEfS7jvj/ukyhKVOMJePA==, picEn=cQ12tu98gbNetbFuefeYGg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509895005466898, language=CN, name=中国临床药理学杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948995591, updatedTime=1788948995591, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://lcylauthor.cast.org.cn/webm, submissionEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionReviewUrl=https://lcylauthor.cast.org.cn/webm, submissionCeEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionAeEditorUrl=https://lcyleditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1304509895047409939, language=EN, name=Chinese Journal of Clinical Pharmacology, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948995601, updatedTime=1788948995601, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=https://lcylauthor.cast.org.cn/webm, submissionEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionReviewUrl=https://lcylauthor.cast.org.cn/webm, submissionCeEditorUrl=https://lcyleditor.cast.org.cn/webm, submissionAeEditorUrl=https://lcyleditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1246415772164075586, websiteList=[Website(id=1246421196657546140, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415772164075586, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN, language=CN, createTime=1775099570670, createBy=18614031015, updateTime=1775099747371, updateBy=18614031015, name=中国临床药理学杂志-中文, tplId=1146099689490845704, title=中国临床药理学杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246422027293316008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=articleTextType, value=kx, createTime=1775099768708, updateTime=1775099768708, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027268150181, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=banner, value=null, createTime=1775099768702, updateTime=1775099768702, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027310093227, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=grayFlag, value=0, createTime=1775099768712, updateTime=1775099768712, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027259761572, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=logo, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/file/pic?fileId=KeUk4pyVjfIIkOq40uZX0Q==, createTime=1775099768700, updateTime=1775099768700, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027322676141, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=minRunFlag, value=0, createTime=1775099768715, updateTime=1775099768715, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027284927399, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/file/pic, createTime=1775099768706, updateTime=1775099768706, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027318481836, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=silenceFlag, value=0, createTime=1775099768714, updateTime=1775099768714, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027276538790, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1775099768704, updateTime=1775099768704, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027297510313, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=themeColor, value=null, createTime=1775099768709, updateTime=1775099768709, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422027305898922, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196657546140, code=themeStyle, value=null, createTime=1775099768711, updateTime=1775099768711, creator=18614031015, updator=18614031015)]), Website(id=1246421196871455649, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1246415772164075586, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN, language=EN, createTime=1775099570720, createBy=18614031015, updateTime=1775099757298, updateBy=18614031015, name=中国临床药理学杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Clinical Pharmacology, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1246422058998059954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=articleTextType, value=kx, createTime=1775099776267, updateTime=1775099776267, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058977088431, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=banner, value=null, createTime=1775099776262, updateTime=1775099776262, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059014837173, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=grayFlag, value=0, createTime=1775099776271, updateTime=1775099776271, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058968699822, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=logo, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/file/pic?fileId=KeUk4pyVjfIIkOq40uZX0Q==, createTime=1775099776260, updateTime=1775099776260, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059031614391, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=minRunFlag, value=0, createTime=1775099776275, updateTime=1775099776275, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058993865649, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/file/pic, createTime=1775099776266, updateTime=1775099776266, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059023225782, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=silenceFlag, value=0, createTime=1775099776273, updateTime=1775099776273, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422058985477040, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1775099776264, updateTime=1775099776264, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059002254259, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=themeColor, value=null, createTime=1775099776268, updateTime=1775099776268, creator=18614031015, updator=18614031015), WebsiteProps(id=1246422059010642868, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1246421196871455649, code=themeStyle, value=null, createTime=1775099776270, updateTime=1775099776270, creator=18614031015, updator=18614031015)])], journalTitle=中国临床药理学杂志, weixinUrl=null, journalUrl=null, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Clinical Pharmacology, journalPhotoCn=8cEfS7jvj/ukyhKVOMJePA==, journalPhotoEn=cQ12tu98gbNetbFuefeYGg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/10.13699/j.cnki.1001-6821.2026.06.016, detailUrlEn=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.06.016, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/PDF/10.13699/j.cnki.1001-6821.2026.06.016, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/PDF/10.13699/j.cnki.1001-6821.2026.06.016, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1774627200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
治疗HER2突变型晚期非小细胞肺癌新药Sevabertinib
收藏切换
PDF下载
曹璐 , 李文静
中国临床药理学杂志 | 新药介绍 2026,42(6): 856-859
收起
收藏切换
中国临床药理学杂志 |新药介绍 2026 , 42 (6) : 856 -859
治疗HER2突变型晚期非小细胞肺癌新药Sevabertinib
全屏
[Author(id=1292130413598761251, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1292130413670064421, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413598761251, language=EN, stringName=Lu CAO, firstName=Lu, middleName=null, lastName=CAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292130413728784678, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413598761251, language=CN, stringName=曹璐, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京医科大学 附属儿童医院 药学部,江苏 南京 210008, bio={"content":"

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

"}, bioImg=null, bioContent=

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292130413523263775, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, xref=null, ext=[AuthorCompanyExt(id=1292130413531652384, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China), AuthorCompanyExt(id=1292130413540040993, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京医科大学 附属儿童医院 药学部,江苏 南京 210008)])]), Author(id=1292130413795893544, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=liwenjing_599@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1292130413888168234, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413795893544, language=EN, stringName=Wen-jing LI, firstName=Wen-jing, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1292130413984637227, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, authorId=1292130413795893544, language=CN, stringName=李文静, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=南京医科大学 附属儿童医院 药学部,江苏 南京 210008, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1292130413523263775, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, xref=null, ext=[AuthorCompanyExt(id=1292130413531652384, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China), AuthorCompanyExt(id=1292130413540040993, tenantId=1146029695717560320, journalId=1246415772164075586, articleId=1292130411459666204, companyId=1292130413523263775, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=南京医科大学 附属儿童医院 药学部,江苏 南京 210008)])])]
曹璐, 李文静
作者信息
  • 南京医科大学 附属儿童医院 药学部,江苏 南京 210008
通讯作者:
李文静,副主任药师 Tel: (025)83117533 E-mail:
作者简介:

曹璐(1987-),女,主管药师,主要从事医院药学与临床药学的工作和研究

Sevabertinib, a novel targeted therapy for HER2-mutated advanced non-small cell lung cancer
Lu CAO, Wen-jing LI
Affiliations
  • Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing 210008, Jiangsu Province, China
出版时间: 2026-03-28 doi: 10.13699/j.cnki.1001-6821.2026.06.016
文章导航
收藏切换

2025年5月,美国食品药品监督管理局(FDA)受理口服人表皮生长因子受体2(HER2)抑制剂Sevabertinib的新药申请(NDA)并授予优先审评资格,该药于2025年11月19日获准上市。Sevabertinib是一种高选择性、可逆的HER2酪氨酸激酶抑制剂,适用于既往接受过系统治疗的HER2激活突变晚期非小细胞肺癌(NSCLC)成人患者。Sevabertinib的上市为NSCLC的辅助治疗提供了新的口服靶向选择。临床研究显示,Sevabertinib在不同治疗人群中均表现出良好的抗肿瘤活性,尤其在未接受HER2靶向治疗患者中客观缓解率(ORR)较高。其常见不良反应包括腹泻、肝毒性及间质性肺病等,总体安全性可控。本文从作用机制、药代动力学、临床疗效、不良反应及药物相互作用等方面对Sevabertinib进行系统综述,以期为临床合理用药提供参考。

Sevabertinib  /  非小细胞肺癌  /  人表皮生长因子受体2突变  /  酪氨酸激酶抑制剂  /  靶向治疗

In May 2025, the U.S. Food and Drug Administration (FDA) accepted and granted priority review for the new drug application (NDA) for the oral human epidermal growth factor receptor 2 (HER2) inhibitor Sevabertinib (Hyrnuo, BAY 2927088), which was subsequently approved on November 19, 2025. Sevabertinib is a highly selective and reversible HER2 tyrosine kinase inhibitor indicated for adult patients with HER2-mutant advanced non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The launch of Sevabertinib provides a new oral targeted option for the adjuvant treatment of NSCLC. Clinical studies have demonstrated promising antitumor activity across different patient populations, with particularly high objective response rates (ORR) in patients without prior HER2-targeted therapy. The most common adverse events include diarrhea, hepatotoxicity, and interstitial lung disease, which are generally manageable. This review summarizes the mechanism of action, pharmacokinetics, clinical efficacy, safety profile, and drug interactions of Sevabertinib to support its rational clinical use.

Sevabertinib  /  non-small cell lung cancer  /  human epidermal growth factor receptor 2 mutation  /  tyrosine kinase inhibitor  /  targeted therapy
曹璐, 李文静. 治疗HER2突变型晚期非小细胞肺癌新药Sevabertinib. 中国临床药理学杂志, 2026 , 42 (6) : 856 -859 . DOI: 10.13699/j.cnki.1001-6821.2026.06.016
Lu CAO, Wen-jing LI. Sevabertinib, a novel targeted therapy for HER2-mutated advanced non-small cell lung cancer[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (6) : 856 -859 . DOI: 10.13699/j.cnki.1001-6821.2026.06.016

参考文献 引证文献
排序方式:
2026年第42卷第6期
PDF下载
182
21
引用本文
BibTeX
文章信息
doi: 10.13699/j.cnki.1001-6821.2026.06.016
  • 接收时间:2026-01-30
  • 首发时间:2026-08-06
  • 出版时间:2026-03-28
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2026-01-30
基金
作者信息
    南京医科大学 附属儿童医院 药学部,江苏 南京 210008

通讯作者:

李文静,副主任药师 Tel: (025)83117533 E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zglcylxzz/CN/10.13699/j.cnki.1001-6821.2026.06.016
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏